WorldViz and SantosHuman Inc. (SHI) have begun co-development to integrate SHI predictive models into the Worldviz VR development platform, enabling users to rapidly develop virtual reality applications that accurately reflect and predict human physical performance and interactions with virtual objects and environments.
Welcome to the University of Iowa Research Park, where collaborative opportunities in technology abound.
We offer corporations locating at the Park convenient, sustained access to the extensive, relevant research resources of The University of Iowa.
Here, growing enterprises have access to a state-of-the art business incubator, world-class research facilities and a dynamic faculty of scientists, physicians and engineers at one of the world’s leading public research universities.
News & Announcements
By Tom Snee 4/18/16
A University of Iowa spinout company that invented a device allowing physically impaired patients to communicate with health care providers expects to launch its product this summer after receiving significant investor interest during clinical trials.
Coralville-based KemPharm's shares are ending the week on a strong note following a big price spike on Wednesday.
The company's chief focus is on developing painkillers that, unlike conventional opiod painkillers, are non-addictive. The FDA accepted an Investigational New Drug Application from KemPharm for KP511, an abuse-deterrent extended release opioid painkiller, at the end of last month.
President Obama announced government plans to spend some $1 billion to fight the opioid addiction crisis on March 29 at the National Rx Drug Abuse and Heroid Summit in Atlanta.